KalVista Pharmaceuticals, Inc. (KALV) Earnings History
Net Loss14 years of earnings data (2013–2026) · Currently unprofitable on a TTM basis
Loading earnings history...
KalVista Pharmaceuticals, Inc. (KALV) Earnings Overview
As of June 22, 2026, KalVista Pharmaceuticals, Inc. (KALV) reported trailing twelve-month net income of -$138M, reflecting +12.5% year-over-year growth. The company earned $-2.74 per diluted share over the past four quarters, with a net profit margin of -223.2%.
Looking at the long-term picture, KALV's historical earnings data spans multiple years. The company achieved its highest annual net income of -$2M in fiscal 2013.
KalVista Pharmaceuticals, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including BDTX (-$43M net income, 32.0% margin), PRAX (-$327M net income), KALA (-$20M net income), KALV has room to improve margins relative to the peer group. Compare KALV vs BDTX →
KALV Earnings vs Peers
Earnings metrics vs comparable public companies
KALV Historical Earnings Data (2013–2026)
14 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2026 | -$164M | +10.4% | -$172M | $-3.23 | -223.2% | -233.4% |
| 2025 | -$183M | -44.9% | -$188M | $-3.69 | - | - |
| 2024 | -$127M | -36.3% | -$140M | $-3.44 | - | - |
| 2023 | -$93M | -12.8% | -$111M | $-3.33 | - | - |
| 2022 | -$82M | -78.1% | -$97M | $-3.36 | - | - |
| 2021 | -$46M | -58.8% | -$58M | $-2.33 | - | - |
| 2020 | -$29M | -39.9% | -$41M | $-1.64 | -229.4% | -319.4% |
| 2019 | -$21M | -31.7% | -$30M | $-1.38 | -129.1% | -184.9% |
| 2018 | -$16M | +15.0% | -$19M | $-1.53 | -188.3% | -222.8% |
| 2017 | -$19M | -62.7% | -$22M | $-1.92 | -1236.9% | -1485.3% |
| 2016 | -$11M | -58.3% | -$15M | $-2.40 | -536.1% | -711.7% |
| 2015 | -$7M | -27.3% | -$8M | $-6.17 | -400.6% | -448.4% |
| 2014 | -$6M | -176.6% | -$5M | $-7.83 | -1368.2% | -1256.9% |
| 2013 | -$2M | - | -$2M | $-2.83 | -133.5% | -119.2% |
Download Data
Export KALV earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
13+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
KALV — Frequently Asked Questions
Quick answers to the most common questions about buying KALV stock.
What is KALV earnings per share (EPS)?
KALV trailing twelve-month (TTM) diluted EPS is $-2.74, reflecting +12.5% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2013 to 2026 is available in the table on this page.
What is KalVista Pharmaceuticals, Inc.'s net income?
KalVista Pharmaceuticals, Inc. (KALV) trailing twelve-month net income is $-138M as of 2026. Earnings grew +12.5% year-over-year.
Is KALV profitable?
KALV is not currently profitable on a TTM basis, reporting a net loss of $-138M. Net margin is -223.2%. Investors should monitor for a return to profitability.
What is KALV's earnings growth rate?
KALV compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2013 to 2026.
What are KALV's profit margins?
KalVista Pharmaceuticals, Inc. net profit margin is -223.2%, operating margin is -233.4%, and gross margin is +91.7%. Below-average margins reflect competitive or cost pressures. Return on Equity is -354.5%.
Is KALV growing earnings?
KALV is growing earnings steadily. YoY EPS growth of +12.5% is consistent with the 5-year CAGR of N/A. TTM net income is $-138M.
What was KALV's best earnings year?
KalVista Pharmaceuticals, Inc.'s highest annual net income on record is $-2M, achieved in fiscal year 2013. Earnings history on this page spans 2013 to 2026 and includes all annual and quarterly figures.
What were KALV's earnings last quarter?
KALV's most recent reported quarter was Q4 2026. Net income was $-23M with diluted EPS of $-1.08. For a full breakdown of all quarters, see the quarterly earnings table on this page.